Boundless Bio Inc
NASDAQ:BOLD
Income Statement
Earnings Waterfall
Boundless Bio Inc
Income Statement
Boundless Bio Inc
| Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||
| Operating Expenses |
(72)
|
(65)
|
(69)
|
(73)
|
(74)
|
(71)
|
(68)
|
|
| Selling, General & Administrative |
(16)
|
(15)
|
(16)
|
(18)
|
(19)
|
(20)
|
(19)
|
|
| Research & Development |
(56)
|
(50)
|
(52)
|
(55)
|
(54)
|
(52)
|
(48)
|
|
| Operating Income |
(72)
N/A
|
(65)
+9%
|
(69)
-6%
|
(73)
-7%
|
(74)
-1%
|
(71)
+3%
|
(68)
+5%
|
|
| Pre-Tax Income | ||||||||
| Interest Income Expense |
7
|
7
|
8
|
8
|
8
|
7
|
6
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(65)
N/A
|
(58)
+11%
|
(61)
-6%
|
(65)
-7%
|
(66)
-1%
|
(64)
+2%
|
(62)
+4%
|
|
| Net Income | ||||||||
| Income from Continuing Operations |
(65)
|
(58)
|
(61)
|
(65)
|
(66)
|
(64)
|
(62)
|
|
| Net Income (Common) |
(65)
N/A
|
(58)
+11%
|
(61)
-6%
|
(65)
-7%
|
(66)
-1%
|
(64)
+2%
|
(62)
+4%
|
|
| EPS (Diluted) |
-2.92
N/A
|
-2.6
+11%
|
-2.75
-6%
|
-3.85
-40%
|
-2.94
+24%
|
-2.88
+2%
|
-2.75
+5%
|
|